Biodesix (BDSX) News Today $1.19 -0.05 (-4.03%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biodesix, Inc. (NASDAQ:BDSX) Director Matthew Strobeck Purchases 40,000 SharesNovember 7, 2024 | insidertrades.comBiodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call TranscriptNovember 4, 2024 | msn.comBiodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 4, 2024 | finance.yahoo.comBiodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Buy" from AnalystsShares of Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) have received an average rating of "Buy" from the seven brokerages that are covering the stock, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokeragesNovember 3, 2024 | marketbeat.comBiodesix (NASDAQ:BDSX) Issues Earnings Results, Beats Expectations By $0.01 EPSBiodesix (NASDAQ:BDSX - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.01. Biodesix had a negative net margin of 73.08% and a negative return on equity of 505.95%. The firm had revenue of $18.15 million for the quarter, compared to the consensus estimate of $18.45 million. During the same period last year, the firm posted ($0.12) earnings per share.November 2, 2024 | marketbeat.comBiodesix Reports Strong Q3 2024 Growth in DiagnosticsNovember 2, 2024 | markets.businessinsider.comBiodesix files to sell 62.2M shares of common stock for holdersNovember 1, 2024 | markets.businessinsider.comBiodesix: Poised for Recovery and Growth Amid Temporary SetbacksNovember 1, 2024 | markets.businessinsider.comBiodesix Announces Third Quarter 2024 Results and HighlightsNovember 1, 2024 | globenewswire.comCraig-Hallum Sticks to Its Buy Rating for Biodesix (BDSX)October 29, 2024 | markets.businessinsider.comBiodesix to Participate in Three Investor Conferences in NovemberOctober 29, 2024 | globenewswire.comBiodesix (BDSX) Set to Announce Quarterly Earnings on FridayBiodesix (NASDAQ:BDSX) will be releasing earnings before the market opens on Friday, November 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637164)October 25, 2024 | marketbeat.comBiodesix to Report Third Quarter 2024 Financial Results on November 1, 2024October 18, 2024 | businesswire.comBiodesix, Inc. (NASDAQ:BDSX) Short Interest Up 29.3% in SeptemberBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 419,700 shares, an increase of 29.3% from the September 15th total of 324,700 shares. Based on an average daily volume of 128,000 shares, the short-interest ratio is presently 3.3 days.October 13, 2024 | marketbeat.comBiodesix (NASDAQ:BDSX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comPerceptive Advisors LLC Takes $3.33 Million Position in Biodesix, Inc. (NASDAQ:BDSX)Perceptive Advisors LLC purchased a new position in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,173,880 shares of the company's stSeptember 30, 2024 | marketbeat.comFarallon Capital Management LLC Purchases New Stake in Biodesix, Inc. (NASDAQ:BDSX)Farallon Capital Management LLC purchased a new stake in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,878,175 shares of the company's stock, valued at approximately $2,874,000. FaraSeptember 24, 2024 | marketbeat.comCraig-Hallum Keeps Their Buy Rating on Biodesix (BDSX)September 21, 2024 | markets.businessinsider.comShort Interest in Biodesix, Inc. (NASDAQ:BDSX) Declines By 15.6%Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 357,500 shares, a decrease of 15.6% from the August 15th total of 423,500 shares. Based on an average daily volume of 143,400 shares, the short-interest ratio is presently 2.5 days.September 16, 2024 | marketbeat.comScotiabank Initiates Coverage on Biodesix (NASDAQ:BDSX)Scotiabank assumed coverage on Biodesix in a research report on Monday. They issued a "sector outperform" rating on the stock.September 16, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Receives Average Recommendation of "Buy" from AnalystsBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) has been given a consensus recommendation of "Buy" by the six research firms that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month target prSeptember 14, 2024 | marketbeat.comAIGH Capital Management LLC Purchases 2,458,727 Shares of Biodesix, Inc. (NASDAQ:BDSX)AIGH Capital Management LLC raised its stake in shares of Biodesix, Inc. (NASDAQ:BDSX - Free Report) by 74.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,779,812 shares of the company's stock after acquiring an aSeptember 9, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Sees Significant Decrease in Short InterestBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the target of a significant decline in short interest in August. As of August 15th, there was short interest totalling 423,500 shares, a decline of 5.9% from the July 31st total of 450,100 shares. Based on an average daily volume of 137,100 shares, the short-interest ratio is presently 3.1 days.September 2, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Given Average Rating of "Buy" by AnalystsBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) has been given an average rating of "Buy" by the six brokerages that are currently covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among analysts tAugust 20, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Sees Large Decline in Short InterestBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 450,100 shares, a decrease of 11.2% from the July 15th total of 506,900 shares. Based on an average daily volume of 144,500 shares, the short-interest ratio is currently 3.1 days.August 17, 2024 | marketbeat.comBiodesix (NASDAQ:BDSX) Announces Earnings Results, Beats Estimates By $0.01 EPSBiodesix (NASDAQ:BDSX - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. Biodesix had a negative return on equity of 29,379.44% and a negative net margin of 85.80%. The company had revenue of $17.93 million for the quarter, compared to the consensus estimate of $16.05 million. During the same period last year, the business posted ($0.17) earnings per share.August 11, 2024 | marketbeat.comStrong Sales Growth and Market Position Justify Buy Rating for BiodesixAugust 10, 2024 | markets.businessinsider.comBuy Rating Justified: Biodesix’s Strong Q2 Performance and Growth ProspectsAugust 10, 2024 | markets.businessinsider.comBiodesix (BDSX) Set to Announce Earnings on WednesdayBiodesix (NASDAQ:BDSX) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=611938)July 31, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Biodesix, Inc. (NASDAQ:BDSX - Get Free Report) have been given a consensus recommendation of "Buy" by the six brokerages that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month targetJuly 26, 2024 | marketbeat.comBiodesix (NASDAQ:BDSX) Receives New Coverage from Analysts at Craig HallumCraig Hallum began coverage on Biodesix in a report on Friday. They issued a "buy" rating and a $3.00 price target for the company.July 26, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Sees Large Increase in Short InterestBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 548,800 shares, an increase of 137.9% from the June 15th total of 230,700 shares. Based on an average daily volume of 173,100 shares, the days-to-cover ratio is presently 3.2 days.July 12, 2024 | marketbeat.comBiodesix (NASDAQ:BDSX) Stock Price Up 1.3%Biodesix (NASDAQ:BDSX) Trading 1.3% HigherJuly 9, 2024 | marketbeat.comBiodesix Named to Inc. Magazine's 2024 “Best Workplaces”June 18, 2024 | businesswire.comBiodesix, Inc. (NASDAQ:BDSX) Sees Significant Decline in Short InterestBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 226,700 shares, a drop of 34.5% from the May 15th total of 346,300 shares. Based on an average daily trading volume, of 141,000 shares, the short-interest ratio is presently 1.6 days.June 15, 2024 | marketbeat.comBiodesix to Participate in Two Investor Conferences in JuneMay 28, 2024 | businesswire.comBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingMay 21, 2024 | finance.yahoo.comBiodesix, Inc. (NASDAQ:BDSX) Short Interest Up 9.7% in AprilBiodesix, Inc. (NASDAQ:BDSX - Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 345,600 shares, a growth of 9.7% from the April 15th total of 315,000 shares. Based on an average daily volume of 140,300 shares, the short-interest ratio is presently 2.5 days.May 16, 2024 | marketbeat.comBuy Rating Justified by Biodesix’s Market Leadership and Strong Growth ProspectsMay 13, 2024 | markets.businessinsider.comBiodesix (NASDAQ:BDSX) Now Covered by Analysts at TD CowenTD Cowen began coverage on Biodesix in a research report on Monday. They set a "buy" rating and a $2.80 price objective on the stock.May 13, 2024 | marketbeat.comBiodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target PriceMay 11, 2024 | finance.yahoo.comBiodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 PerformanceMay 10, 2024 | finance.yahoo.comBiodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comBiodesix First Quarter 2024 Earnings: Beats ExpectationsMay 10, 2024 | finance.yahoo.comBiodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...May 9, 2024 | finance.yahoo.comBDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | investorplace.comBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementMay 8, 2024 | finance.yahoo.comBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceMay 7, 2024 | businesswire.comBiodesix (NASDAQ:BDSX) Earns Buy Rating from Analysts at Lake Street CapitalLake Street Capital assumed coverage on Biodesix in a research note on Friday. They issued a "buy" rating and a $3.00 price target for the company.May 3, 2024 | marketbeat.comBiodesix (BDSX) Scheduled to Post Earnings on WednesdayBiodesix (NASDAQ:BDSX) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588280)May 1, 2024 | marketbeat.com Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. BDSX Media Mentions By Week BDSX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDSX News Sentiment▼-1.000.45▲Average Medical News Sentiment BDSX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDSX Articles This Week▼01▲BDSX Articles Average Week Get Biodesix News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RNLX News Today AGL News Today INNV News Today SHCR News Today FLGT News Today AUNA News Today GRAL News Today CELC News Today DCGO News Today EHAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDSX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodesix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodesix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
